Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Nov '25 Nov 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,032	948	-	-
Enterprise Value	731	428	-	-
Last Close Price	18.04	17.42	-	-
PB Ratio	2.45	1.93	-	-
P/TBV Ratio	2.53	1.93	-	-
Debt / Equity Ratio	0.01	0.00	0.00	-
Quick Ratio	13.80	27.22	15.28	0.17
Current Ratio	14.14	27.93	15.32	0.21
Return on Equity (ROE)	-26.64%	-19.14%	-51.67%	-
Return on Assets (ROA)	-18.59%	-13.84%	-20.72%	-
Return on Capital (ROIC)	-19.28%	-14.47%	-24.70%	-
Return on Capital Employed (ROCE)	-35.00%	-16.70%	-18.20%	219.00%
Earnings Yield	-11.93%	-7.17%	-	-
FCF Yield	-11.10%	-7.89%	-	-
Buyback Yield / Dilution	-1559.37%	-2796.96%	-35.20%	-

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q